Cognition Therapeutics Files 8-K

Ticker: CGTX · Form: 8-K · Filed: May 8, 2025 · CIK: 1455365

Cognition Therapeutics INC 8-K Filing Summary
FieldDetail
CompanyCognition Therapeutics INC (CGTX)
Form Type8-K
Filed DateMay 8, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, routine-reporting

TL;DR

Cognition Therapeutics filed a routine 8-K on May 8, 2025. No major news.

AI Summary

Cognition Therapeutics, Inc. filed an 8-K on May 8, 2025, reporting other events and financial statements. The filing does not contain specific financial figures or material events beyond routine reporting requirements.

Why It Matters

This 8-K filing indicates routine corporate reporting by Cognition Therapeutics, Inc. to the SEC, without detailing specific material events or financial performance.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for other events and financial statements, with no disclosed material changes or significant financial information.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Cognition Therapeutics, Inc.?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of May 8, 2025.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on May 8, 2025.

In which state is Cognition Therapeutics, Inc. incorporated?

Cognition Therapeutics, Inc. is incorporated in Delaware.

What is the SEC file number for Cognition Therapeutics, Inc.?

The SEC file number for Cognition Therapeutics, Inc. is 001-40886.

What is the business address of Cognition Therapeutics, Inc. as listed in the filing?

The business address listed is 2500 Westchester Ave. Purchase, NY 10577.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding COGNITION THERAPEUTICS INC (CGTX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing